Cited by — UB-312, an investigational active immunotherapy targeting α-synuclein, enhances survival of a peripherally-seeded mouse model of synucleinopathy | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite UB-312, an investigational active immunotherapy targeting α-synuclein, enhances survival of a peripherally-seeded mouse model of synucleinopathy.
No admitted local citation edges point to this work yet.
